Pediatric Vaccines Market Expand to Hit Big Revenue With R&D of new vaccines

Growing awareness regarding vaccines and immunization among the populace is propelling the growth of the global pediatric vaccines market. For example, in the U.S., the month of January is celebrated as Cervical Health Awareness Month, wherein the importance of regular vaccination and screening in the prevention of cancer is forwarded. Also, increasing incidences of invasive cervical cancer are again anticipated to foster the growth of the market.

Request Here Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/1708

According to the American Cancer Society, about 13,800 new cases of invasive cervical cancer are expected to be diagnosed in the U.S. in 2020 and the disease is expected to lead to the death of 4,290 women in the same year. The American Academy of Pediatrics recommends HPV vaccination for both females and males between the ages of 9 and 12, as vaccinations are more effective before any exposure to the virus.

In December 2019, Soligenix, Inc. initiated the study to assess the Safety of RiVax, a lyophilized ricin toxin A-chain subunit vaccine with alum-adjuvant

In April 2018, Merck & Co, Inc. initiated two Phase III studies of PCV-15 (V114), an investigational polyvalent conjugate vaccine for the prevention of pneumococcal disease.

For instance, according to the World Health Organization in 2018, around 19.4 million children under the age of one year did not receive basic vaccines. Around 60% of these children belonged to emerging countries such as Angola, Brazil, the Democratic Republic of the Congo, Ethiopia, India, Indonesia, Nigeria, Pakistan, the Philippines, and Viet Nam.

Pediatric vaccines protect children from infectious agents like viruses, bacteria, and fungi that can cause serious diseases like smallpox, measles, mumps, and chickenpox. They also prevent diseases caused by these agents in adults. Vaccines are mostly made to protect against diseases that spread through mosquitoes. This includes yellow fever, dengue, and malaria. A pediatric vaccine, usually given to infants below 6 years of age, is the rotavirus. An important part of the routine schedule of vaccinations is the rotavirus vaccine, given in two doses along with the other required doses of a diphtheria-to vaccine or a varicella-zoster vaccine.

Major Market Competitors: GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Panacea Biotec, Zydus Cadila, Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech, and Indian Immunologicals Ltd.

Download PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1708

Contact us:
Mr. Shah
Senior Client Partner – Business Development
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
sales@coherentMarketinsights.com

𝗔𝗯𝗼𝘂𝘁 𝗖𝗼𝗵𝗲𝗿𝗲𝗻𝘁 𝗠𝗮𝗿𝗸𝗲𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:-
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunities.

This release was published on openPR.